<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7320840\results\search\disease\results.xml">
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="of COVID-19 as a global pandemic. Abstract Currently, pandemic coronavirus" exact="disease" post="2019 (COVID-19) is the biggest threat to all human"/>
  <result pre="identified in a patient with influenza-like symptoms along with severe" exact="acute" post="respiratory syndrome in Wuhan, China, in December 2019 and"/>
  <result pre="in a patient with influenza-like symptoms along with severe acute" exact="respiratory" post="syndrome in Wuhan, China, in December 2019 and now"/>
  <result pre="a patient with influenza-like symptoms along with severe acute respiratory" exact="syndrome" post="in Wuhan, China, in December 2019 and now it"/>
  <result pre="200 countries. Since there is no approved cure for this" exact="disease" post="until now, there is a lot of mass fear,"/>
  <result pre="(iii) what could be the potential vaccine targets. In this" exact="short" post="review, we have tried to address these queries in"/>
  <result pre="to cure the disease. Keywords COVID-19 Novel coronavirus Pandemic nCoV" exact="Pneumonia" post="ACE2 Plasma therapy Introduction The novel coronavirus disease 2019"/>
  <result pre="Pandemic nCoV Pneumonia ACE2 Plasma therapy Introduction The novel coronavirus" exact="disease" post="2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2"/>
  <result pre="Introduction The novel coronavirus disease 2019 (COVID-19) caused by severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency,"/>
  <result pre="The novel coronavirus disease 2019 (COVID-19) caused by severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency, posing"/>
  <result pre="novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2) is a public health emergency, posing a"/>
  <result pre="system worldwide. On February 11, 2020, World Health Organization named" exact="disease" post="caused by a novel coronavirus (2019-nCoV) as coronavirus disease"/>
  <result pre="named disease caused by a novel coronavirus (2019-nCoV) as coronavirus" exact="disease" post="2019 (COVID-19) [1, 2]. Initially, this was identified in"/>
  <result pre="HKU1, and 229E predominantly infect humans and usually cause moderate" exact="respiratory" post="tract illness such as common cold [10]. The two"/>
  <result pre="common cold [10]. The two other strains which cause severe" exact="acute" post="respiratory syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV)"/>
  <result pre="cold [10]. The two other strains which cause severe acute" exact="respiratory" post="syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) are"/>
  <result pre="[10]. The two other strains which cause severe acute respiratory" exact="syndrome" post="(SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) are zoonotic"/>
  <result pre="which cause severe acute respiratory syndrome (SARS-CoV) and Middle East" exact="Respiratory" post="Syndrome (MERS-CoV) are zoonotic in origin and have been"/>
  <result pre="cause severe acute respiratory syndrome (SARS-CoV) and Middle East Respiratory" exact="Syndrome" post="(MERS-CoV) are zoonotic in origin and have been related"/>
  <result pre="are zoonotic in origin and have been related to deadly" exact="infections" post="[11â€&quot;14]. SARS-CoV was the causal agent of the severe"/>
  <result pre="infections [11â€&quot;14]. SARS-CoV was the causal agent of the severe" exact="acute" post="respiratory syndrome outbreaks in 2002 and 2003 in Guangdong"/>
  <result pre="[11â€&quot;14]. SARS-CoV was the causal agent of the severe acute" exact="respiratory" post="syndrome outbreaks in 2002 and 2003 in Guangdong Province,"/>
  <result pre="SARS-CoV was the causal agent of the severe acute respiratory" exact="syndrome" post="outbreaks in 2002 and 2003 in Guangdong Province, China"/>
  <result pre="are controversies about the source of the COVID-19 and its" exact="intermediate" post="host, the evolutionary analysis showed that the coronavirus was"/>
  <result pre="in the genome of nCoV [19]. Along with flu and" exact="respiratory" post="problems, people of all ages are susceptible to COVID-19,"/>
  <result pre="and there was no significant gender bias in terms of" exact="viral infection" post="[2]. Recent researches have revealed that COVID-19 is less"/>
  <result pre="there was no significant gender bias in terms of viral" exact="infection" post="[2]. Recent researches have revealed that COVID-19 is less"/>
  <result pre="have revealed that COVID-19 is less lethal in children than" exact="adult" post="patients, though some infants were vulnerable to infection [20]."/>
  <result pre="children than adult patients, though some infants were vulnerable to" exact="infection" post="[20]. Also, prominent changes were seen in the blood"/>
  <result pre="[21]. It is also reported that the patients with pre-existing" exact="cardiovascular" post="metabolic diseases such as hypertension, cardia-cerebrovascular diseases, and diabetes"/>
  <result pre="It is also reported that the patients with pre-existing cardiovascular" exact="metabolic diseases" post="such as hypertension, cardia-cerebrovascular diseases, and diabetes are at"/>
  <result pre="pre-existing cardiovascular metabolic diseases such as hypertension, cardia-cerebrovascular diseases, and" exact="diabetes" post="are at a greater risk of developing severe conditions"/>
  <result pre="distinct from SARS-CoV in terms of the phylogeny of the" exact="complete" post="RNA-dependent RNA polymerase (RdRP) gene, reiterating that it is"/>
  <result pre="the nCoV receptor-binding domain, composed of a core and an" exact="external" post="subdomain which is similar to that of SARS-CoV suggesting"/>
  <result pre="found in the nucleocapsid of virus particles and binds the" exact="viral" post="genome in a beads-on-a-string type conformation. N protein is"/>
  <result pre="and the M protein, and these protein interactions tether the" exact="viral" post="genome to the replicase-transcriptase complex and package the encapsulated"/>
  <result pre="to the replicase-transcriptase complex and package the encapsulated genome into" exact="viral" post="particles [33â€&quot;38]. Fig. 1 Novel coronavirus genome and structure."/>
  <result pre="[33â€&quot;38]. Fig. 1 Novel coronavirus genome and structure. a The" exact="viral" post="genome consists of two partially overlapping replicase open reading"/>
  <result pre="frames (OFR1a and 1b) and several downstream ORFs that encode" exact="viral" post="functional structural proteins and other proteins. b Schematic representation"/>
  <result pre="nCoV from other CoV strains. Therefore, timely detection of nCoV" exact="infection" post="cases is very important to stop the community spread."/>
  <result pre="has a broad antiviral activity and is known to inhibit" exact="viral" post="replication through premature termination of RNA transcription. There are"/>
  <result pre="show promise for the treatment of hospitalized COVID-19 patients with" exact="pneumonia" post="in a recent clinical trial in China [52]. Recently,"/>
  <result pre="prescription drugs that have been used for the treatment of" exact="malaria" post="and certain inflammatory conditions like rheumatoid arthritis, systemic lupus"/>
  <result pre="for the treatment of malaria and certain inflammatory conditions like" exact="rheumatoid arthritis," post="systemic lupus erythematosus, and porphyria cutanea tarda. Both of"/>
  <result pre="treatment of malaria and certain inflammatory conditions like rheumatoid arthritis," exact="systemic" post="lupus erythematosus, and porphyria cutanea tarda. Both of these"/>
  <result pre="of malaria and certain inflammatory conditions like rheumatoid arthritis, systemic" exact="lupus erythematosus," post="and porphyria cutanea tarda. Both of these drugs have"/>
  <result pre="certain inflammatory conditions like rheumatoid arthritis, systemic lupus erythematosus, and" exact="porphyria" post="cutanea tarda. Both of these drugs have in vitro"/>
  <result pre="clinical trials of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2" exact="infection" post="are going on. Although its temporary use on patients"/>
  <result pre="first time use of convalescent plasma for the cure of" exact="diphtheria" post="in 1901 by Nobel Prize winner (Physiology and Medicine)"/>
  <result pre="We have been under the continuous invasion of deadly virus" exact="infections" post="like SARS-CoV, Ebola, Nipah, and Zika in recent years."/>
  <result pre="be crucial in therapeutic design to prevent COVID-19: The Spike" exact="Protein" post="The spike (S) protein from coronaviruses has been reported"/>
  <result pre="protein from coronaviruses has been reported to be a crucial" exact="viral" post="antigen which stimulates a strong humoral and cell-mediated immune"/>
  <result pre="known to mediate receptor binding and virus entry during host" exact="infection" post="[14]. The role of S protein in receptor binding"/>
  <result pre="induce antibodies to block virus binding and fusion or neutralize" exact="virus infection" post="[56]. Although to date, there are no certified vaccines"/>
  <result pre="antibodies to block virus binding and fusion or neutralize virus" exact="infection" post="[56]. Although to date, there are no certified vaccines"/>
  <result pre="between its RBD region and the hCD26 receptor to initiate" exact="infection" post="[56, 59, 60], interrupting this interaction could abrogate virus"/>
  <result pre="could be a great prospective site for drug design. ACE2" exact="Protein" post="structure modeling studies have shown that (ACE2) is the"/>
  <result pre="them. Recent studies have confirmed that nCoV binds to ACE2." exact="Structural" post="analysis of potential interactions between RBD of S protein"/>
  <result pre="and nCoV spike protein would probably decrease the rate of" exact="viral infection" post="and could be a strong target for therapeutic designs."/>
  <result pre="nCoV spike protein would probably decrease the rate of viral" exact="infection" post="and could be a strong target for therapeutic designs."/>
  <result pre="serves as a ligand for the binding of a transmissible" exact="gastroenteritis" post="virus (TGEV), which is an enteropathogenic porcine coronavirus to"/>
  <result pre="the virions by the binding of the virus to sialoglycoconjugates." exact="Increased" post="stability would help virions to survive the passage through"/>
  <result pre="year 2020. Clinicians are advised to see the Centers for" exact="Disease" post="Control and Prevention (CDC), USA, website for changes in"/>
  <result pre="USA, website for changes in guidance for testing, treatment, and" exact="infection" post="control. Response actions against the ferocious nCoV must be"/>
  <result pre="Until a new vaccine against nCoV becomes available, avoidance of" exact="viral" post="spreading is the most appropriate way to flatten the"/>
  <result pre="1.Su YJ, Lai YC. Comparison of clinical characteristics of coronavirus" exact="disease" post="(COVID-19) and severe acute respiratory syndrome (SARS) as experienced"/>
  <result pre="Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe" exact="acute" post="respiratory syndrome (SARS) as experienced in Taiwan. Travel Med"/>
  <result pre="of clinical characteristics of coronavirus disease (COVID-19) and severe acute" exact="respiratory" post="syndrome (SARS) as experienced in Taiwan. Travel Med Infect"/>
  <result pre="clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory" exact="syndrome" post="(SARS) as experienced in Taiwan. Travel Med Infect Dis."/>
  <result pre="YH, Hsueh SC, Yen MY, et al. Asymptomatic carrier state," exact="acute" post="respiratory disease, and pneumonia due to severe acute respiratory"/>
  <result pre="Hsueh SC, Yen MY, et al. Asymptomatic carrier state, acute" exact="respiratory" post="disease, and pneumonia due to severe acute respiratory syndrome"/>
  <result pre="MY, et al. Asymptomatic carrier state, acute respiratory disease, and" exact="pneumonia" post="due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2):"/>
  <result pre="carrier state, acute respiratory disease, and pneumonia due to severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J"/>
  <result pre="state, acute respiratory disease, and pneumonia due to severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol"/>
  <result pre="acute respiratory disease, and pneumonia due to severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol"/>
  <result pre="on animal reservoirs of the SARS coronavirusVirus Res2008133748717451830 7.ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother."/>
  <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58:4875â€&quot;84."/>
  <result pre="Bushmaker T, Feldmann F, Brining DL, et al. Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection"/>
  <result pre="T, Feldmann F, Brining DL, et al. Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) causes transient lower respiratory tract infection in"/>
  <result pre="DL, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes" exact="transient" post="lower respiratory tract infection in rhesus macaques. Proc Natl"/>
  <result pre="et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient" exact="lower" post="respiratory tract infection in rhesus macaques. Proc Natl Acad"/>
  <result pre="al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower" exact="respiratory" post="tract infection in rhesus macaques. Proc Natl Acad Sci"/>
  <result pre="East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract" exact="infection" post="in rhesus macaques. Proc Natl Acad Sci U S"/>
  <result pre="Novel Coronavirus, and Team ResearchA novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773331978945 15.DrostenCGuntherSPreiserWvan der WerfSBrodtHRBeckerSRabenauHPanningMKolesnikovaLFouchierRABergerABurguiereAMCinatlJEickmannMEscriouNGrywnaKKrammeSManuguerraJCMullerSRickertsVSturmerMViethSKlenkHDOsterhausADSchmitzHDoerrHWIdentification"/>
  <result pre="der WerfSBrodtHRBeckerSRabenauHPanningMKolesnikovaLFouchierRABergerABurguiereAMCinatlJEickmannMEscriouNGrywnaKKrammeSManuguerraJCMullerSRickertsVSturmerMViethSKlenkHDOsterhausADSchmitzHDoerrHWIdentification of a novel coronavirus in patients with severe" exact="acute" post="respiratory syndromeN Engl J Med20033481967197612690091 16.KsiazekTGErdmanDGoldsmithCSZakiSRPeretTEmerySTongSUrbaniCComerJALimWRollinPEDowellSFLingAEHumphreyCDShiehWJGuarnerJPaddockCDRotaPFieldsBDeRisiJYangJYCoxNHughesJMLeDucJWBelliniWJAndersonLJcollab: Sars Working GroupA"/>
  <result pre="WerfSBrodtHRBeckerSRabenauHPanningMKolesnikovaLFouchierRABergerABurguiereAMCinatlJEickmannMEscriouNGrywnaKKrammeSManuguerraJCMullerSRickertsVSturmerMViethSKlenkHDOsterhausADSchmitzHDoerrHWIdentification of a novel coronavirus in patients with severe acute" exact="respiratory" post="syndromeN Engl J Med20033481967197612690091 16.KsiazekTGErdmanDGoldsmithCSZakiSRPeretTEmerySTongSUrbaniCComerJALimWRollinPEDowellSFLingAEHumphreyCDShiehWJGuarnerJPaddockCDRotaPFieldsBDeRisiJYangJYCoxNHughesJMLeDucJWBelliniWJAndersonLJcollab: Sars Working GroupA novel"/>
  <result pre="Med20033481967197612690091 16.KsiazekTGErdmanDGoldsmithCSZakiSRPeretTEmerySTongSUrbaniCComerJALimWRollinPEDowellSFLingAEHumphreyCDShiehWJGuarnerJPaddockCDRotaPFieldsBDeRisiJYangJYCoxNHughesJMLeDucJWBelliniWJAndersonLJcollab: Sars Working GroupA novel coronavirus associated with severe" exact="acute" post="respiratory syndromeN Engl J Med20033481953196612690092 17.ZhongNSZhengBJLiYMPoonZXieHChanKHLiPHTanSYChangQXieJPLiuXQXuJLiDXYuenKYPeirisGuanYEpidemiology and cause of"/>
  <result pre="16.KsiazekTGErdmanDGoldsmithCSZakiSRPeretTEmerySTongSUrbaniCComerJALimWRollinPEDowellSFLingAEHumphreyCDShiehWJGuarnerJPaddockCDRotaPFieldsBDeRisiJYangJYCoxNHughesJMLeDucJWBelliniWJAndersonLJcollab: Sars Working GroupA novel coronavirus associated with severe acute" exact="respiratory" post="syndromeN Engl J Med20033481953196612690092 17.ZhongNSZhengBJLiYMPoonZXieHChanKHLiPHTanSYChangQXieJPLiuXQXuJLiDXYuenKYPeirisGuanYEpidemiology and cause of severe"/>
  <result pre="respiratory syndromeN Engl J Med20033481953196612690092 17.ZhongNSZhengBJLiYMPoonZXieHChanKHLiPHTanSYChangQXieJPLiuXQXuJLiDXYuenKYPeirisGuanYEpidemiology and cause of severe" exact="acute" post="respiratory syndrome (SARS) in Guangdong, Peopleâ€™s Republic of China,"/>
  <result pre="syndromeN Engl J Med20033481953196612690092 17.ZhongNSZhengBJLiYMPoonZXieHChanKHLiPHTanSYChangQXieJPLiuXQXuJLiDXYuenKYPeirisGuanYEpidemiology and cause of severe acute" exact="respiratory" post="syndrome (SARS) in Guangdong, Peopleâ€™s Republic of China, in"/>
  <result pre="Engl J Med20033481953196612690092 17.ZhongNSZhengBJLiYMPoonZXieHChanKHLiPHTanSYChangQXieJPLiuXQXuJLiDXYuenKYPeirisGuanYEpidemiology and cause of severe acute respiratory" exact="syndrome" post="(SARS) in Guangdong, Peopleâ€™s Republic of China, in February,"/>
  <result pre="Q, Li Y, Foley BT, et al. Evolutionary history, potential" exact="intermediate" post="animal host, and cross-species analyses of SARS-CoV-2. J Med"/>
  <result pre="al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus" exact="disease" post="in China. Pediatrics. 2020. 10.1542/peds.2020-0702. 21.Han H, Yang L,"/>
  <result pre="Wang X, Liu L, et al. Prevalence and impact of" exact="cardiovascular" post="metabolic diseases on COVID-19 in China. Clin Res Cardiol."/>
  <result pre="X, Liu L, et al. Prevalence and impact of cardiovascular" exact="metabolic diseases" post="on COVID-19 in China. Clin Res Cardiol. 2020a. 10.1007/s00392-020-01626-9."/>
  <result pre="Res Cardiol. 2020a. 10.1007/s00392-020-01626-9. 23.WHO Situation Report â€&quot;51 (2020) Coronavirus" exact="disease" post="2019 (COVID-19). Available at:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 24.CucinottaDVanelliMWHO declares COVID-19 a pandemicActa"/>
  <result pre="COVID-19 a pandemicActa Biomed20209115716032191675 25.WHO Situation Report âˆ’140 (2020) Coronavirus" exact="disease" post="2019 (COVID-19). Available https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200608-covid-19-sitrep-140.pdf?sfvrsn=2f310900_2 26.LukHKHLiXFungJLauSKPWooPCYMolecular epidemiology, evolution and phylogeny"/>
  <result pre="protein in coronavirus assembly and morphologyJ Struct Biol2011174112221130884 32.DeDiegoMLAlvarezEAlmazanFRejasMTLamirandeERobertsAShiehWJZakiSRSubbaraoKEnjuanesLA severe" exact="acute" post="respiratory syndrome coronavirus that lacks the E gene is"/>
  <result pre="in coronavirus assembly and morphologyJ Struct Biol2011174112221130884 32.DeDiegoMLAlvarezEAlmazanFRejasMTLamirandeERobertsAShiehWJZakiSRSubbaraoKEnjuanesLA severe acute" exact="respiratory" post="syndrome coronavirus that lacks the E gene is attenuated"/>
  <result pre="coronavirus assembly and morphologyJ Struct Biol2011174112221130884 32.DeDiegoMLAlvarezEAlmazanFRejasMTLamirandeERobertsAShiehWJZakiSRSubbaraoKEnjuanesLA severe acute respiratory" exact="syndrome" post="coronavirus that lacks the E gene is attenuated in"/>
  <result pre="Virol2013875182519223449786 36.MolenkampRSpaanWJIdentification of a specific interaction between the coronavirus mouse" exact="hepatitis" post="virus A59 nucleocapsid protein and packaging signalVirology199723978869426448 37.NalBChanCKienFSiuLTseJChuKKamJStaropoliICrescenzo-ChaigneBEscriouNet al.Differential"/>
  <result pre="packaging signalVirology199723978869426448 37.NalBChanCKienFSiuLTseJChuKKamJStaropoliICrescenzo-ChaigneBEscriouNet al.Differential maturation and subcellular localization of severe" exact="acute" post="respiratory syndrome coronavirus surface proteins S, M and EJ"/>
  <result pre="signalVirology199723978869426448 37.NalBChanCKienFSiuLTseJChuKKamJStaropoliICrescenzo-ChaigneBEscriouNet al.Differential maturation and subcellular localization of severe acute" exact="respiratory" post="syndrome coronavirus surface proteins S, M and EJ Gen"/>
  <result pre="37.NalBChanCKienFSiuLTseJChuKKamJStaropoliICrescenzo-ChaigneBEscriouNet al.Differential maturation and subcellular localization of severe acute respiratory" exact="syndrome" post="coronavirus surface proteins S, M and EJ Gen Virol2005861423143415831954"/>
  <result pre="Virol2005861423143415831954 38.SturmanLSHolmesKVBehnkeJIsolation of coronavirus envelope glycoproteins and interaction with the" exact="viral" post="nucleocapsidJ Virol1980334494626245243 39.LiFStructure, function, and evolution of coronavirus spike"/>
  <result pre="43.Schwegmann-WesselsCBauerSWinterCEnjuanesLLaudeHHerrlerGThe sialic acid binding activity of the S protein facilitates" exact="infection" post="by porcine transmissible gastroenteritis coronavirusVirol J2011843521910859 44.Schwegmann-WesselsCHerrlerGSialic acids as"/>
  <result pre="activity of the S protein facilitates infection by porcine transmissible" exact="gastroenteritis" post="coronavirusVirol J2011843521910859 44.Schwegmann-WesselsCHerrlerGSialic acids as receptor determinants for coronavirusesGlycoconj"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 46.MackayIMArdenKEMERS coronavirus: diagnostics,"/>
  <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends202014727332074550 56.DuLYangYZhouYLuLLiFJiangSMERS-CoV spike protein: a key"/>
  <result pre="a key target for antiviralsExpert Opin Ther Targets20172113114327936982 57.PapaneriABJohnsonRFWadaJBollingerLJahrlingPBKuhnJHMiddle East" exact="respiratory" post="syndrome: obstacles and prospects for vaccine developmentExpert Rev Vaccines20151494996225864502"/>
  <result pre="BJ, et al. Risk for transportation of 2019 novel coronavirus" exact="disease" post="from Wuhan to other cities in China. Emerg Infect"/>
  <result pre="J Infect. 2020. 10.1016/j.jinf.2020.02.026. 67.PensaertMCoxEvan DeunKCallebautPA sero-epizootiological study of porcine" exact="respiratory" post="coronavirus in Belgian swineVet Q19931516208388592 68.SchultzeBEnjuanesLHerrlerGAnalysis of the sialic"/>
  <result pre="Q19931516208388592 68.SchultzeBEnjuanesLHerrlerGAnalysis of the sialic acid-binding activity of the transmissible" exact="gastroenteritis" post="virusAdv Exp Med Biol19953803673708830509 69.HerrlerGGrossHJBrossmerRA synthetic sialic acid analog"/>
  <result pre="used by influenza C virus as a receptor determinant for" exact="infection" post="of cellsBiochem Biophys Res Commun19952168218277488199"/>
 </snippets>
</snippetsTree>
